These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 301030)

  • 21. Gastrointestinal system involvement in systemic lupus erythematosus.
    Li Z; Xu D; Wang Z; Wang Y; Zhang S; Li M; Zeng X
    Lupus; 2017 Oct; 26(11):1127-1138. PubMed ID: 28523968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus.
    Bluestein HG; Williams GW; Steinberg AD
    Am J Med; 1981 Feb; 70(2):240-6. PubMed ID: 7468611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central nervous system involvement in childhood systemic lupus erythematosus.
    Yancey CL; Doughty RA; Athreya BH
    Arthritis Rheum; 1981 Nov; 24(11):1389-95. PubMed ID: 7317116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease.
    Feinglass EJ; Arnett FC; Dorsch CA; Zizic TM; Stevens MB
    Medicine (Baltimore); 1976 Jul; 55(4):323-39. PubMed ID: 781466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-ELISA detection of antineuronal antibodies in central nervous system involvement in systemic lupus erythematosus.
    Zhang X; Shu H; Zhang F; Tian X; Dong Y
    Ann Rheum Dis; 2007 Apr; 66(4):530-2. PubMed ID: 16905576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid interleukin-6, prostaglandin E2 and autoantibodies in patients with neuropsychiatric systemic lupus erythematosus and central nervous system infections.
    Tsai CY; Wu TH; Tsai ST; Chen KH; Thajeb P; Lin WM; Yu HS; Yu CL
    Scand J Rheumatol; 1994; 23(2):57-63. PubMed ID: 8165438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
    Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases.
    Kang EH; Shen GQ; Morris R; Metzger A; Lee EY; Lee YJ; Lee EB; Song YW
    Lupus; 2008 Jan; 17(1):21-5. PubMed ID: 18089679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The deoxyribonucleic acid (DNA) skin test in systemic lupus erythematosus. I. Clinical evaluation.
    Johansson EA; Kiistala U; Niemi KM; Halme H; Lassus A
    Br J Dermatol; 1975 Oct; 93(4):443-50. PubMed ID: 1103938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction.
    Winfield JB; Brunner CM; Koffler D
    Arthritis Rheum; 1978 Apr; 21(3):289-94. PubMed ID: 306251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiganglioside antibodies in cerebrospinal fluid of children with neuropsychiatric lupus erythematosus.
    Chen Y; Wu F; Hou L; Ma S; He X
    Chin Med J (Engl); 1997 Aug; 110(8):594-7. PubMed ID: 9594260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomographic classification of 82 events in 71 patients.
    Kaell AT; Shetty M; Lee BC; Lockshin MD
    Arch Neurol; 1986 Mar; 43(3):273-6. PubMed ID: 3947277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease.
    Kozora E; West SG; Kotzin BL; Julian L; Porter S; Bigler E
    Arthritis Rheum; 1998 Jan; 41(1):41-7. PubMed ID: 9433868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technetium-99m thyroid scan; does it have a diagnostic aid in sub-clinical auto-immune thyroid disease in systemic lupus erythematosus patients?
    Amin A; Alkemary A; Abdo M; Salama M
    Lupus; 2016 Feb; 25(2):155-61. PubMed ID: 26345676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement.
    Lin WY; Wang SJ; Yen TC; Lan JL
    J Nucl Med; 1997 Jul; 38(7):1112-5. PubMed ID: 9225800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuropsychiatric involvement in systemic lupus erythematosus. Part 2: diagnostic and therapy].
    Weiner SM; Otte A; Uhl M; Brink I; Schumacher M; Peter HH
    Med Klin (Munich); 2003 Feb; 98(2):79-90. PubMed ID: 12601532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The treatment of SLE: the case of conservative management.
    Hughes GR
    Clin Rheum Dis; 1982 Apr; 8(1):299-313. PubMed ID: 6214364
    [No Abstract]   [Full Text] [Related]  

  • 38. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement.
    Trysberg E; Carlsten H; Tarkowski A
    Lupus; 2000; 9(7):498-503. PubMed ID: 11035414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus.
    Carreño L; López-Longo FJ; Monteagudo I; Rodríguez-Mahou M; Bascones M; González CM; Saint-Cyr C; Lapointe N
    Lupus; 1999; 8(4):287-92. PubMed ID: 10413207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus.
    Nishimura K; Harigai M; Omori M; Sato E; Hara M
    Psychoneuroendocrinology; 2008 Apr; 33(3):395-403. PubMed ID: 18261856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.